|
KMID : 0614720220650020117
|
|
Journal of Korean Medical Association
2022 Volume.65 No. 2 p.117 ~ p.122
|
|
|
Pharmacological management of muscle spasticity
|
|
Ko Eun-Jae
Kim Dae-Yul
|
|
|
Abstract
|
|
|
Background: Muscle spasticity is a neurologic disorder, which is considered one of the positive signs of upper motor neuron diseases. Spasticity is common after brain or spinal cord injury. Since spasticity results in tendon retraction, muscle weakness, pain, ankylosis, and disability in activities of daily living, treatment is warranted.
Current Concepts: Spasticity is usually assessed using the Modified Ashworth Scale or Modified Tardieu Scale.
It is treated with various methods, including physical therapy, occupational therapy, orthosis, medication, and surgery. Pharmacological management should be selected according to the location and severity of the symptom and includes oral medications, chemical nerve block, and intrathecal baclofen pump insertion. Oral medications include baclofen, benzodiazepine, dantrolene, and tizanidine. Chemoneurolysis of spasticity is done with botulinum toxin or a mixture of phenol and alcohol.
Discussion and Conclusion: Since muscle spasticity affects motor function and activities of daily living, understanding of
this symptom and choosing an optimal treatment are necessary. Pharmacologic treatments should be administered with caution especially with the side effects. Optimal treatment of spasticity will bring the best neurological outcome for the patients.
|
|
|
KEYWORD
|
|
|
Muscle spasticity, Drug therapy, Motor activity, Activities of daily living
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
 
|
|